The U.S. Court of Appeals for the Federal Circuit confirmed that its review of trial court determinations regarding patent infringement complaints is de novo, establishing a clearer standard of review.
AlexSam's allegations against Aetna involved its claims that Aetna's products infringed on a patent that had expired and was initially licensed to another party, raising complexities regarding prior licensing.
The case emphasizes the significance of license agreements and their implications for future litigation, particularly concerning the covenant not to sue and its expiration upon the patent's end.
In light of the complexities surrounding the licensed transactions, AlexSam's attempt to argue that the Mastercard Products fell outside the prior license agreements underscores the intricate nature of patent law.
Collection
[
|
...
]